Search results
Hal Mark Schrock, DDS - Picayune Item
The Picayune Item· 20 hours agoArrangements are under the direction of McDonald Funeral Home. Hal Mark Schrock was born on July 7, 1953, and passed peacefully to his eternal home...
Innovent Reports Oncology Pipeline Updates at Investor Meeting
Morningstar· 7 days agoSAN FRANCISCO and SUZHOU, China, June 18, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ...
Short Interest in Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Drops By 7.0%
ETF DAILY NEWS· 6 days agoBolt Biotherapeutics, Inc. (NASDAQ:BOLT – Get Free Report) was the recipient of a large decline in short interest in May. As of May 31st, there was short interest totalling 1,980,000 shares, ...
Rockville cancer therapy company set to IPO this week - Washington Business Journal
The Business Journals· 7 days agoOS Therapies Inc., a Rockville biotech advancing a treatment for a rare cancer plaguing kids, is...
Christus Health encourages checkups for Men's Health Month
The Marshall News Messenger· 4 days agoJune is Men’s Health Month and Christus Health is encouraging men to prioritize their health by...
GenFleet Receives IND Approval from China's NMPA for GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor,...
Tehachapi News· 6 days agoG12D mutation is the most prevalent KRAS mutation detected in human cancers, and no G12D-targeted therapies have been approved yet.
Regeneron (NASDAQ:REGN): Is This Stock-Split Contender a Strong Buy?
TipRanks via Yahoo Finance· 5 days agoRegeneron (NASDAQ:REGN) stock has more than tripled in value in the past five years, with the price...
Gateway - Quartz
Quartz· 7 days agoMeanwhile, Pfizer announced Wednesday another cost-cutting initiative as the company struggles with diminishing demand for its COVID-19 vaccine. A U.S. Food and Drug Administration (FDA) advisory ...
Chemotherapy Before Surgery Benefits Some Patients | Newswise
Newswise· 5 days agoPatients with pancreatic cancer who received chemotherapy both before and after surgery experienced longer survival rates than would be expected from surgery followed by chemotherapy ...
Actuate Therapeutics (ACTU) to Raise $50 Million in IPO
ETF DAILY NEWS· 6 days agoActuate Therapeutics (ACTU) plans to raise $50 million in an initial public offering on the week of...
